4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-003157
Options or other derivatives
- Senior VP and General Counsel acquired 84,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LADD CYNTHIA J · Senior VP and General Counsel
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-01-25 | Grant or award : show line 1 in the form Stock Option (right to buy) | +84,000 | 84,000 | D |
Loading xslF345X03/doc1.xml…